Paysign Announces Leadership Appointments to Drive Patient Affordability Business Line
01 June 2020 - 10:31PM
Business Wire
Paysign, Inc. (NASDAQ:PAYS), a vertically integrated provider of
innovative prepaid card programs, digital banking, and processing
services for corporate, consumer, and government applications,
today announced three leadership appointments. Each appointee will
be focused on enhancing Paysign’s Patient Affordability
capabilities and will have a reporting relationship to Alberto
Negron, Executive Vice President Channel Strategy.
Burke Williams has been appointed Senior Vice President of
Business Development. In this role Williams will focus on expanding
our HUB and Copay marketing client base. Williams will also focus
on expanding our market reach to include non-profit organizations
and foundations for their patient assistance programs. A proven
industry veteran, Williams brings a wealth of experience to
Paysign, having held a variety of roles at TrialCard, Inc. over a
15-year period, most recently as VP of Business Development,
Patient Reimbursement and Engagement Strategy.
Matthew Turner has been named Vice President, Head of Patient
Affordability Solutions. Turner is responsible for developing and
managing Paysign’s Patient Affordability services. A ten year
veteran of the healthcare and pharmaceutical services industry,
Turner most recently served as Director of Product Management for
TrialCard Inc, where he was responsible for risk mitigation,
compliance, and pharmacy product lines.
Brett Squire has been appointed Senior Director, Client Services
and Informatics. Squire has worked with brands across
numerous therapeutic areas, both within the manufacturer and as a
service vendor. Prior to working with Paysign, he worked for
Fortovia Therapeutics as the Director of Business Analysis and
Automation. Before joining Fortovia, Squire worked for TrialCard
Inc. as the Director of Client Services where he supported his
manufacturing clients with Hub Services and Patient Affordability
Solutions.
“I am extremely pleased to welcome Burke, Matt and Brett to our
Patient Affordability team,” said Mark Newcomer, Chief Executive
Officer, Paysign. “They are all recognized industry leaders with
demonstrated track records of success. Given their collective
experience in patient affordability, we are well positioned to
accelerate our growth in the space”.
With new opportunities opening in the space, Paysign has
expanded beyond our long-standing pharmaceutical payment offerings
and established a Patient Affordability business-line to include
other services required by our HUB clients. These new services
include: pharmacy-based co-pay, medical claims processing and
payments, centralized billing, and payment services, as well as
other products. To learn more, visit
https://paysign.com/solutions/pharmaceutical-services/.
About Paysign, Inc.
Paysign, Inc (NASDAQ: PAYS) is an experienced and trusted
prepaid debit card payment solutions provider as well as an
integrated payment processor that has managed millions of prepaid
debit cards in its portfolio. Paysign conceptualizes, develops and
manages payment solutions, prepaid card programs, and customized
payment services. Paysign’s corporate incentive prepaid cards are
changing the way corporations reward, motivate, and engage their
current and potential customers, employees, and agents. Paysign’s
customizable solutions offer significant cost savings while
improving brand recognition and customer loyalty. For over 15 years
healthcare companies, major pharmaceutical companies,
multinationals, prestigious universities, and social media
companies have relied on Paysign to provide state of the art
prepaid payment programs tailored to their unique requirements.
Paysign is a registered trademark of Paysign, Inc. in the United
States and other countries. For more information visit us at
paysign.com, or follow us on Facebook, Twitter, and LinkedIn.
Forward-Looking Statements
Certain statements contained in this press release may be deemed
to be forward-looking statements under federal securities laws, and
the company intends that such forward-looking statements be subject
to the safe-harbor created thereby. All statements, other than
statements of fact, included in this release, are forward-looking
statements. Such forward-looking statements include, among others,
expanding long-standing pharmaceutical payment offerings and
enhancing Patient Affordability capabilities. We caution that these
statements are qualified by important risks, uncertainties, and
other factors that could cause actual results to differ materially
from those reflected by such forward-looking statements. Such
factors include, among others, the inability to continue our
current growth rate in future periods; identified material
weaknesses in our internal control over financial reporting which
could, if not remediated, adversely affect our ability to report
our financial condition and results of operations in a timely and
accurate manner; that a downturn in the economy, including as a
result of COVID-19, could reduce our customer base and demand for
our products and services, which could have an adverse effect on
our business, financial condition, profitability, and cash flows;
operating in a highly regulated environment; failure by us or
business partners to comply with applicable laws and regulations;
changes in the laws, regulations, credit card association rules or
other industry standards affecting our business; that a data
security breach could expose us to liability and protracted and
costly litigation; and other risk factors set forth in our Form
10-K for the year ended December 31, 2019. Except to the extent
required by federal securities laws, the company undertakes no
obligation to publicly update or revise any statements in this
release, whether as a result of new information, future events, or
otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200601005034/en/
Paysign, Inc. Jim McCroy, 1-702-749-7269 Investor Relations
ir@Paysign.com www.Paysign.com
Paysign (NASDAQ:PAYS)
Historical Stock Chart
From Apr 2024 to May 2024
Paysign (NASDAQ:PAYS)
Historical Stock Chart
From May 2023 to May 2024